Literature DB >> 484498

Role of prostaglandin E1 infusion in the management of transposition of the great arteries.

L N Benson, P M Olley, R G Patel, F Coceani, R D Rowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 484498     DOI： 10.1016/0002-9149(79)90289-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

Review 1.  Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.

Authors:  S C Reddy; A Saxena
Journal:  Indian J Pediatr       Date:  1998 Mar-Apr       Impact factor: 1.967

2.  Management of cyanotic congenital heart disease with increased pulmonary blood flow.

Authors:  R P Sapru; V R Pillai
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

Review 3.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

4.  Use of prostaglandin E2 in management of transposition of great arteries before balloon atrial septostomy.

Authors:  A Beitzke; C H Suppan
Journal:  Br Heart J       Date:  1983-04

5.  Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.

Authors:  M Tohyama; A Baba; T Tsuno; K Aonuma; A Komiyama
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

6.  Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.

Authors:  B D Thanopoulos; A Andreou; C Frimas
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

7.  Responsiveness of the ductus arteriosus to prostaglandin E1 assessed by combined cross sectional and pulsed Doppler echocardiography.

Authors:  S Hiraishi; N Fujino; K Saito; K Oguchi; N Kadoi; Y Agata; Y Horiguchi; H Hozumi; K Yashiro
Journal:  Br Heart J       Date:  1989-08

8.  Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.

Authors:  F Coceani; P M Olley; J E Lock
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

9.  Congenital Heart Disease Requiring Maintenance of Ductus Arteriosus in Critically Ill Newborns Admitted at a Tertiary Neonatal Intensive Care Unit.

Authors:  Manuela Cucerea; Marta Simon; Elena Moldovan; Marcela Ungureanu; Raluca Marian; Laura Suciu
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08

Review 10.  Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.

Authors:  Smita Akkinapally; Shilpa G Hundalani; Madhulika Kulkarni; Caraciolo J Fernandes; Antonio G Cabrera; Binoy Shivanna; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2018-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.